Today: 9 April 2026
XRP price today: Ripple-linked token can’t get back above $2 as tariff jitters hit crypto
21 January 2026
1 min read

XRP price today: Ripple-linked token can’t get back above $2 as tariff jitters hit crypto

NEW YORK, Jan 21, 2026, 13:57 ET — Regular session

XRP hovered near $1.89 on Wednesday, slipping 0.17% in the past 24 hours, unable to break above the $2 mark. Trading volume clocked in at roughly $4.0 billion over the same period. According to CoinMarketCap, XRP holds the fifth spot by market capitalization. CoinMarketCap

The shift follows traders dialing back risk asset exposure after U.S. President Donald Trump revived tariff threats against European nations linked to Greenland. That rattled U.S. stocks, sparking their sharpest one-day drop in three months on Tuesday. Bitcoin tumbled more than 3% during the selloff, despite usually finding some support in defensive moves. Reuters

Leverage played a key role Monday as crypto markets saw $869.5 million in positions liquidated over the past 24 hours, according to Coinglass data cited by Investing.com. Most of those wiped-out bets were long positions. (Liquidations occur when leveraged trades hit margin limits.) XRP dropped 4.7%, slipping below $2 during the sell-off. Investing.com

Over the past 24 hours, XRP fluctuated roughly between $1.88 and $1.95, per Kraken pricing. The $2 level has regained attention, largely because it attracts concentrated orders on both sides. Kraken

Broader crypto dipped as well. Bitcoin slipped roughly 1.2%, hovering near $88,338, while ether dropped about 2.2% to close to $2,924, per market data.

Anthony Scaramucci, founder and managing partner at SkyBridge Capital, pointed to policy uncertainty as the driver behind ongoing market volatility. “This is more of a timing issue than a direction issue,” he noted, maintaining that the long-term outlook for digital assets remains intact despite short-term turbulence hitting crowded trades. Reuters

Interest-rate expectations continue to influence crypto, which often follows wider financial trends. A Reuters poll showed every economist surveyed predicts the Federal Reserve will hold rates steady at its Jan. 27-28 meeting. Jeremy Schwartz of Nomura added that the Fed is likely to “remain on hold” until the end of Chair Jerome Powell’s term in May. Reuters

The downside risk is clear: one more shock headline or a fresh wave of forced selling could drive XRP sharply back to recent lows if liquidity dries up. That same leverage that fuels rallies can also amplify declines when stop-losses trigger.

XRP ranks among the top cryptocurrencies by market value and powers Ripple’s network for payments and transfers. This makes it vulnerable to changes in crypto sentiment as well as broader shifts in risk appetite.

The upcoming focus is the U.S. data calendar. At 8:30 a.m. ET on Jan. 22, the Bureau of Economic Analysis will release its updated third-quarter GDP estimate. Then, at 10:00 a.m. ET, the personal income and outlays report is set to follow. Both reports have the potential to shift rate expectations and, consequently, impact risk assets like crypto. Bureau of Economic Analysis

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:11 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Natural gas price jumps toward $5 on cold-flip trade, lifting EQT and Range stocks
Previous Story

Natural gas price jumps toward $5 on cold-flip trade, lifting EQT and Range stocks

Intel stock jumps nearly 9% as AI chip trade steadies; Nvidia rebounds
Next Story

Intel stock jumps nearly 9% as AI chip trade steadies; Nvidia rebounds

Go toTop